There have been no adverse functions attributed to your therapy, which resulted in a one hundred pc decrease in unbound N-terminal tau fragments in CSF. There were no effects on exploratory measures of illness severity.In spite of these promising advances, there are actually problems to deal with. Longitudinal experiments are important to verify no